Publication: Feasibility of dsRNA treatment for post-clearing SPF shrimp stocks of newly discovered viral infections using Laem Singh virus (LSNV) as a model
Issued Date
2017-05-02
Resource Type
ISSN
18727492
01681702
01681702
Other identifier(s)
2-s2.0-85018484424
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Virus Research. Vol.235, (2017), 73-76
Suggested Citation
Vanvimon Saksmerprome, Patai Charoonnart, Timothy W. Flegel Feasibility of dsRNA treatment for post-clearing SPF shrimp stocks of newly discovered viral infections using Laem Singh virus (LSNV) as a model. Virus Research. Vol.235, (2017), 73-76. doi:10.1016/j.virusres.2017.04.012 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/41886
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Feasibility of dsRNA treatment for post-clearing SPF shrimp stocks of newly discovered viral infections using Laem Singh virus (LSNV) as a model
Other Contributor(s)
Abstract
© 2017 Elsevier B.V. Using post-larvae derived from specific pathogen free (SPF) stocks in penaeid shrimp farming has led to a dramatic increase in production. At the same time, new pathogens of farmed shrimp are continually being discovered. Sometimes these pathogens are carried by shrimp and other crustaceans as persistent infections without gross signs of disease. Thus it is that a 5-generation stock of Penaeus monodon SPF for several pathogens was found, post-stock-development, to be persistently-infected with newly-discovered Laem Singh virus (LSNV). In this situation, the stock developers were faced with destroying their existing stock (developed over a long period at considerable cost) and starting the whole stock development process anew in order to add LSNV to its SPF list. As an alternative, it was hypothesized that injection of complementary dsRNA into viral-infected broodstock prior to mating might inhibit replication of the target virus sufficiently to reduce or eliminate its transmission to their offspring. Subsequent selection of uninfected offspring would allow for post-clearing of LSNV from the existing stock and for conversion of the stock to LSNV-free status. Testing this hypothesis using the LSNV-infected stock described above, we found that transmission was substantially reduced in several treated broodstock compared to much higher transmission in buffer-injected broodstock. Based on these results, the model is proposed for post-clearing of SPF stocks using dsRNA treatment. The model may also be applicable to post-clearing of exceptional, individual performers from grow-out ponds for return to a nucleus breeding center.